MRNA Moderna is set for a pivotal FDA flu vaccine decision. The FDA will likely decide this week whether or not to approve Moderna’s experim
MRNA Moderna is set for a pivotal FDA flu vaccine decision. The FDA will likely decide this week whether or not to approve Moderna’s experimental mRNA influenza vaccine — potentially the first licensed flu shot based on mRNA technology - STAT News
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.